📊 Score Breakdown
Offering Ability
60
Cash Runway
65
Float Risk
25
Warrant Exposure
70
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
40%
📉 Score Deterioration
50%
• Score rose 46 points recently (worsening)
• Score in HIGH risk zone (66/100)
📜 Warrant Exercise
40%
• Significant warrants: 24% of shares outstanding
• Elevated warrant risk score (70/100)
💰 Capital Raise
15%
• Under 12 months cash (8mo)
💹 Market Data
Market Cap$14.19M
Shares Outstanding3.36M
Float3.04M
Cash$6.82M
Debt$518.0K
Short InterestN/A
🏛 Institutional Holdings
6.8% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
📉 Short Interest
Short Interest239.0K
Days to Cover3.8
% of Float7.9%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
xbrl
XBRL CONVERTIBLE
Dec 31, 2019
4
INSIDER TRANSACTION
Feb 26, 2026
4
INSIDER TRANSACTION
Feb 26, 2026
4
INSIDER TRANSACTION
Feb 26, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for AQMS
📊 AQMS FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 AQMS Signal Convergence & Dark Pool Activity — StonkWhisper
📄 AQMS Dilution Risk Analysis — Full In-Depth Report
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.